mechlorethamine has been researched along with 4-hydroxycyclophosphamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eubanks, N; Gilbert, DN; Starr, P | 1 |
| Atzpodien, J; Clarkson, BD; Colvin, OM; Gulati, SC; Jain, K; Langleben, A; Ng, RP; Shimazaki, C; Yopp, J | 1 |
| Ara, G; Bunnell, C; Elias, A; Frei, E; Richardson, P; Teicher, B; Tew, K; Wheeler, C | 1 |
3 other study(ies) available for mechlorethamine and 4-hydroxycyclophosphamide
| Article | Year |
|---|---|
Inhibition of neutrophil chemotaxis by 4-hydroxycyclophosphamide.
Topics: Alkylating Agents; Chemotaxis, Leukocyte; Cyclophosphamide; Humans; In Vitro Techniques; Mechlorethamine; Neutrophils; Nitrogen Mustard Compounds | 1977 |
Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow.
Topics: Antineoplastic Agents; B-Lymphocytes; Bleomycin; Bone Marrow; Cell Line; Cell Separation; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Mechlorethamine; Vincristine | 1988 |
Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Breast Neoplasms; Carmustine; Cell Survival; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Mechlorethamine; Melphalan; Mice; Neoplasms, Experimental; Tumor Cells, Cultured | 2000 |